Home › Free Stock Grades › HROW
Harrow Health, Inc. (HROW) Stock Grade
HROW · Healthcare
C
Market Cap
$1.2B
P/E Ratio
—
Revenue Growth (YoY)
+36.4%
Net Margin
-1.9%
Return on Equity
—
Dividend Yield
None
About Harrow Health, Inc.'s fundamentals
Harrow Health is a specialty and generic drug manufacturer with a market capitalization of $1.2 billion that has achieved strong revenue growth of 36.4% year-over-year. Despite this robust top-line expansion, the company operated at a net margin of -1.9% in its latest reporting period, reflecting a net loss for the year. However, the company generated positive free cash flow despite its accounting losses, suggesting operational cash generation that exceeds non-cash charges. The company does not currently pay a dividend.